Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Role of TNF in mast cell neuroinflammation and pain.
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica.
MRI correlates of disability progression in patients with CIS over 48 months.
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
Abnormal brain iron metabolism in irp2 deficient mice is associated with mild neurological and behavioral impairments.
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
MicroRNA-145 as one negative regulator of astrogliosis.
A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis.
Assessing the safety of biologic agents in patients with rheumatoid arthritis.
Accelerated Axonal Loss Following Acute CNS Demyelination in Mice Lacking Protein Tyrosine Phosphatase Receptor Type Z.
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Pages
« first
‹ previous
…
373
374
375
376
377
378
379
380
381
…
next ›
last »